103 related articles for article (PubMed ID: 33833084)
1. A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18-45 genotyping in Cameroon.
Vassilakos P; Wisniak A; Catarino R; Tincho Foguem E; Balli C; Saiji E; Tille JC; Kenfack B; Petignat P
Int J Gynecol Cancer; 2021 Jun; 31(6):808-816. PubMed ID: 33833084
[TBL] [Abstract][Full Text] [Related]
2. Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.
Bao H; Ma L; Zhao Y; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wu J; Wang HJ
Cancer Commun (Lond); 2022 Mar; 42(3):191-204. PubMed ID: 35142100
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
Cook DA; Krajden M; Brentnall AR; Gondara L; Chan T; Law JH; Smith LW; van Niekerk DJ; Ogilvie GS; Coldman AJ; Warman R; Reuter C; Cuzick J; Lorincz AT
Int J Cancer; 2019 May; 144(10):2587-2595. PubMed ID: 30412281
[TBL] [Abstract][Full Text] [Related]
4. Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy.
Broquet C; Vassilakos P; Ndam Nsangou FM; Kenfack B; Noubom M; Tincho E; Jeannot E; Wisniak A; Petignat P
BMJ Open; 2022 Dec; 12(12):e057234. PubMed ID: 36549727
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia.
Murillo R; Gamboa O; Hernández G; González M; Olejua P; Molano M; Wiesner C
Prev Med; 2021 Dec; 153():106801. PubMed ID: 34508733
[TBL] [Abstract][Full Text] [Related]
8. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
9. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
10. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
Song F; Du H; Wang C; Huang X; Qu X; Wei L; Belinson JL; Wu R;
J Med Screen; 2021 Sep; 28(3):318-324. PubMed ID: 32869705
[TBL] [Abstract][Full Text] [Related]
13. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
Wright TC; Stoler MH; Parvu V; Yanson K; Cooper C; Andrews J
Gynecol Oncol; 2019 Aug; 154(2):360-367. PubMed ID: 31160073
[TBL] [Abstract][Full Text] [Related]
14. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
Zhao Y; Bao H; Ma L; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wang HJ; Wu J
BMC Med; 2021 Jul; 19(1):164. PubMed ID: 34261463
[TBL] [Abstract][Full Text] [Related]
15. Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.
Xue H; Gao H; Zheng J; Chen Y; Chen J; Pan D; Dong B; Sun P
J Cancer; 2021; 12(14):4332-4340. PubMed ID: 34093833
[No Abstract] [Full Text] [Related]
16. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms.
Luo H; Du H; Belinson JL; Wu R
PLoS One; 2019; 14(7):e0220200. PubMed ID: 31348794
[TBL] [Abstract][Full Text] [Related]
18. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
19. Options for triage and implications for colposcopists within European HPV-based cervical screening programmes.
Leeson S; Alalade R; Singh N; Nieminen P; Cruickshank M; Carcopino X; Bergeron C
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():332-342. PubMed ID: 33524777
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort.
Song F; Du H; Xiao A; Wang C; Huang X; Liu Z; Zhao M; Men H; Wu R
J Infect Public Health; 2020 Nov; 13(11):1780-1786. PubMed ID: 32919932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
